SEC 13F Intelligence

Forefront Wealth Management Inc. / REGN

Forefront Wealth Management Inc.’s Regeneron Pharmaceuticals Position

Does Forefront Wealth Management Inc. own Regeneron Pharmaceuticals (REGN)? Yes — 2.8K shares worth $2M (+1.58% of its 13F portfolio) as of Q4 2025, down from 2.9K shares the prior filed quarter.

Position Value
$2M
Q4 2025
Shares
2.8K
% of Portfolio
+1.58%
Quarters Held
13
currently held

Position History REGN

Reported value by quarter
Q4 ’21: $3MQ4 ’21Q1 ’22: $4MQ2 ’22: $3MQ2 ’22Q3 ’22: $4MQ4 ’22: $4MQ4 ’22Q1 ’23: $3MQ2 ’23: $2MQ2 ’23Q3 ’23: $3MQ4 ’24: $2MQ4 ’24Q1 ’25: $2MQ2 ’25: $2MQ2 ’25Q3 ’25: $2MQ4 ’25: $2MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20252.8K$2M+1.58%
Q3 20252.9K$2M+1.19%
Q2 20253.0K$2M+1.27%
Q1 20253.1K$2M+1.83%
Q4 20243.1K$2M+2.03%
Q3 20233.1K$3M+3.58%
Q2 20233.1K$2M+2.94%
Q1 20233.1K$3M+3.36%
Q4 20225.1K$4M+4.98%
Q3 20225.2K$4M+4.96%
Q2 20225.3K$3M+4.22%
Q1 20225.1K$4M+3.49%
Q4 20215.1K$3M+3.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Forefront Wealth Management Inc.’s full portfolio or all institutional holders of REGN.